Joint Formulary & PAD

Sumatriptan with naproxen - Migraine (acute)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative
Formulations :
  • Tablets
Associated Icons :
NFD2
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Sumatriptan with naproxen
Indication :
Migraine (acute)
Group Name :
Keywords :
Acute migraine, migraine treatment, triptans
Brand Names Include :
Suvexx
Important Information :

Not assessed for inclusion on the formulary. Contact pharmacy team for advice on making an application.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Sumatriptan with naproxen is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Migraine (acute).

Committee Recommendations (1)

04 Jun 25 - Not Set

This drug has not yet been assessed for formulary status and is not currently on the APC work-plan.

This drug has not yet been evaluated by the Surrey Heartlands ICS Area Prescribing Committee (APC).  As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. 

Before prescribing this drug, it is recommended that clinicians contact their Medicines Optimisation team to discuss possible alternatives/options.

The APC will consider recommending the prescribing of this treatment upon submission of a formal request with its associated evidence. Clinicians can contact syheartlandsicb.APC@nhs.net  if they wish to make a submission.